Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cerebrovascular Event”

312 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 312 results

Not applicableStudy completedNCT01502683
What this trial is testing

Stroke Study: Operative Strategies to Reduce Cerebral Embolic Events During Coronary Artery Bypass Surgery

Who this might be right for
Stroke
Emory University 193
Large-scale testing (Phase 3)Study completedNCT04078737
What this trial is testing

Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II

Who this might be right for
StrokeTransient Ischemic Attack
Beijing Tiantan Hospital 6,412
Post-approval studies (Phase 4)Study completedNCT02426944
What this trial is testing

Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Charles University, Czech Republic 400
Large-scale testing (Phase 3)Study completedNCT01073800
What this trial is testing

Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill

Who this might be right for
Myocardial InfarctionStrokeRenal Failure
University of Alberta 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07359872
What this trial is testing

Relaxin Therapy for Atrial Fibrillation

Who this might be right for
Atrial Fibrillation (AF)ArrhythmiaOxidative Stress+5 more
Deeptankar DeMazumder 208
Not applicableEnded earlyNCT03783754
What this trial is testing

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial Magnetic Resonance Imaging Sub-study

Who this might be right for
StrokeCerebral Small Vessel DiseasesIntracerebral Hemorrhage+2 more
The George Institute 4
Post-approval studies (Phase 4)Study completedNCT03090113
What this trial is testing

Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism

Who this might be right for
Embolic Stroke
Beijing Tiantan Hospital 2,416
Not applicableUnknownNCT01509924
What this trial is testing

Cognitive and Physical Functions in Patients With Transient Ischemic Attack. A Randomized Controlled Trial of Physical Activity on Prescription up to One Year After the Event

Who this might be right for
Ischemic Attack, Transient
Tiohundra AB 100
Not applicableLooking for participantsNCT04839887
What this trial is testing

Factors Affecting the Quality of Life After Ischemic Stroke in Young Adults

Who this might be right for
Ischemic Stroke
Elena Gurkova 520
Not applicableLooking for participantsNCT06473272
What this trial is testing

Evaluation of Vulnerability of Carotid Plaques and Prediction of Cardio-Cerebrovascular Event Using Ultrasonic Imaging

Who this might be right for
Carotid PlaqueIschemic StrokeCardiovascular Events
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 600
Not applicableActive Not RecruitingNCT06855394
What this trial is testing

Genetic Testing of CYP2C19 in Prognostic Evaluation of Long-Term Major Adverse Cardiac and Vascular Events

Who this might be right for
Atherosclerotic Vascular DiseaseCoronary Arterial Disease (CAD)Atherosclerosis of Coronary Artery+4 more
University of Florida 13,000
Large-scale testing (Phase 3)UnknownNCT02221102
What this trial is testing

Edoxaban for TIA and Acute Minor Stroke

Who this might be right for
IschemiaStrokeCerebral Infarction
Xijing Hospital 3,700
Large-scale testing (Phase 3)Enrolling By InvitationNCT06908473
What this trial is testing

Tongmai Jiangtang Capsule for Cardiovascular Clinical Outcomes in High-Risk Metabolic Syndrome Patients

Who this might be right for
Metabolic SyndromeCardiovascular Disease (CKD)Cerebrovascular Disease+1 more
Guangdong Provincial Hospital of Traditional Chinese Medicine 530
Not applicableUnknownNCT00846924
What this trial is testing

30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation After a Cerebral Ischemic Event

Who this might be right for
StrokeTransient Ischemic AttackAtrial Fibrillation+1 more
Sunnybrook Health Sciences Centre 564
Large-scale testing (Phase 3)Ended earlyNCT00120289
What this trial is testing

Niacin Plus Statin to Prevent Vascular Events

Who this might be right for
Cardiovascular DiseasesHeart DiseasesCerebrovascular Accident+3 more
Axio Research. LLC 3,414
Post-approval studies (Phase 4)Study completedNCT00327418
What this trial is testing

CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events

Who this might be right for
Major Coronary EventCerebrovascular AccidentCoronary Artery Bypass Graft+2 more
Pfizer 2,800
Large-scale testing (Phase 3)Study completedNCT00526474
What this trial is testing

Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737)

Who this might be right for
AtherosclerosisIschemiaMyocardial Infarction+2 more
Merck Sharp & Dohme LLC 26,449
Not applicableActive Not RecruitingNCT06295679
What this trial is testing

A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease

Who this might be right for
Major Cardiovascular EventEstablished Atherosclerotic Cardiovascular Disease
Amgen 7,000
Not applicableStudy completedNCT04776226
What this trial is testing

Post-stroke Depression Treatment Effect on Stroke Recurrence

Who this might be right for
Stroke RecurrenceCardiovascular EventsDepression
Ege University 1,230
Not applicableWithdrawnNCT03804125
What this trial is testing

Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery

Who this might be right for
Cerebral StrokeThrombosis, Deep VeinPulmonary Embolism
Pfizer
Next Page